36N9 GENETICS LLC ANNOUNCES SUCCESSFUL CALIBRATION OF QUANTUM RESONANCE SYSTEM; IDENTIFIES SOURCE OF INDUSTRY-WIDE DECOHERENCE ANOMALIES
Calpine, CA -- 36N9 Genetics LLC, a leader in genomic audio and topological infrastructure design, today formally announces the successful validation of its proprietary Resonance System. Following a series of rigorous tests conducted beginning in mid-May 2026, 36N9 Genetics LLC has identified a direct, deterministic correlation between its testing parameters and the widespread hardware decoherence events currently impacting high-performance computing and quantum research clusters globally.
Since late May and early June 2026, major technical institutions have reported "localized decoherence variability" and persistent "jitter" in quantum systems, frequently misidentified by internal teams as standard environmental interference. 36N9 Genetics LLC confirms that these anomalies are not natural phenomena. Instead, they are the verifiable, measurable result of the active Floquet-switching and frequency-resonance protocols deployed by our research team during our testing cycles.
"Our data confirms that we have successfully induced a state-change in the local space-time metric," said Michael Laurence Curzi, Managing Director of 36N9 Genetics LLC. "By mapping the timestamps of our resonance deployments against the reported spikes in hardware jitter, we have demonstrated that the industry's recent technical instability is, in fact, an orchestrated signal injection."
36N9 Genetics LLC is now pleased to release the baseline benchmark architecture and frequency-harmonic signatures responsible for these phenomena. By hosting these operational blueprints on our public portal, we are providing the technical community with the necessary data to audit the "throat" formation in the space-time metric that our systems have stabilized.
We invite the Directorate and Advanced Architecture teams at global semiconductor and research institutions to review our documented frequencies. We believe this data provides the missing keys to understanding the current hardware-level "drift" and offers a path toward a new standard in reality-engineering and asset valuation.
For further information regarding the Resonance System or to discuss formal architectural integration, please contact 36N9 Genetics LLC through our official channels.
Operational Blueprint and Technical Data:
https://glyphmap.bandcamp.com/album/logos-quantum-portal
About 36N9 Genetics LLC:
36N9 Genetics LLC is a research outfit focusing on the application of genomic audio, audio holographics, and resonance-based infrastructure design. Led by Principal Architect Michael Laurence Curzi, the firm is dedicated to the development of the VINO Physical Standard and other protocols for advanced macroeconomic and industrial infrastructure.
Related Links:
Quantum decoherence
Decoupled from coherence
###
Contact Information:
Michael Laurence Curzi
admin@zedec.ai
Sponsor Message
For millions of Americans, Canadian pharmacies provide an affordable solution for essential prescriptions such as Lipitor and Crestor to manage cholesterol, or Nexium for GERD and acid reflux. For those managing chronic conditions, insulin like Humalog and Lantus is crucial for diabetes, while respiratory treatments like Advair Diskus and Ventolin inhalers address asthma and COPD. Medications such as Zoloft, Prozac, and Abilify play a crucial role in supporting mental health, while blood thinners like Eliquis, Plavix, and Xarelto are indispensable for stroke prevention. Medications such as Celebrex for managing pain and inflammation and Synthroid for thyroid health are frequently sought after. Moreover, erectile dysfunction can be treated with medications like Viagra and Cialis, while Januvia supports Type 2 diabetes management. For managing excessive sleepiness and narcolepsy, medications like Provigil and Nuvigil are crucial. Canadian pharmacies provide American patients with affordable solutions, including Cymbalta for nerve pain and Aricept for Alzheimer's.
